RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

RaySearch Laboratories AB (publ)

RaySearch Laboratories develops software for radiation therapy and oncology, focusing on advancing cancer treatment through technology. The solutions support clinics worldwide in the fight against cancer.

msh id	COM:RAYSEARCHLABS
symbol	RAY-B
name	RaySearch Laboratories AB (publ)
homepage url	https://www.raysearchlabs.com
country	SE
sector	Healthcare
industry	Medical - Healthcare Information Services
market	STOCKS
employee count	398
crunchbase url	-
linkedin url	-
founders	-

market cap	432.38M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	8.48K
monthly webtraffic growth	0.44
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.11
growth cost of revenue	3.12
growth depreciation and amortization	-0.04
growth ebitda	0.19
growth ebitda ratio	-0.02
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-1
growth gross profit	-0.16
growth gross profit ratio	-0.31

COM:RAYSEARCHLABS

RaySearch Laboratories

Last Close

194.00

21/11 16:29

Market Cap

4.61B

Beta: -

Volume Today

83.84K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	83.22M
cost of revenue	83.22M
depreciation and amortization	26.31M
ebitda	37.36M
ebitda ratio	0.4
eps	0.22
eps diluted	0.22
operating expenses	47.09M
operating income	11.05M
operating income ratio	0.12

accounts receivables	2.93M
capital expenditure	-19.31M
cash at beginning of period	14.78M
cash at end of period	31.7M
inventory	859.61K
working capital ttm	124.41M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-